NCT02451813

Brief Summary

Recent evidence suggests that injection pressure monitoring may be able to predict needle nerve contact in the brachial plexus nerve block model, but little is known about multifascicular nerves. The investigators hypothesize that injection pressure monitoring can reliably predict needle-nerve contact during femoral nerve block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 3, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 22, 2015

Completed
Last Updated

April 15, 2016

Status Verified

March 1, 2015

Enrollment Period

5 months

First QC Date

March 3, 2015

Last Update Submit

April 13, 2016

Conditions

Keywords

opening injection pressurefemoral nerve blockfascia iliacaultrasound guided nerve block

Outcome Measures

Primary Outcomes (1)

  • Incidence of high opening injection pressure (15 psi or greater) when needle tip in contact with nerve

    1 minute

Secondary Outcomes (3)

  • Incidence of high opening injection pressure (15 psi or greater) at other needle locations

    1 minute

  • Minimum threshold current to elicit a motor response with needle-nerve contact and needle disengagement

    1 minute

  • Incidence of paresthesias

    1 week

Study Arms (1)

Intervention

EXPERIMENTAL

A 22 GA 5 cm nerve block needle will be advanced to the following conditions: 1. Needle tip slightly indenting the fascia iliaca 2. Needle tip advanced through fascia iliaca 3. Needle tip slightly indenting the anterior surface of the femoral nerve 4. Needle tip withdrawn 1 mm from nerve. At each of these conditions, 1 ml of dextrose solution will be injected and spread of injectate observed sonographically. A blinded observer will measure injection pressure. If opening pressure reaches 15 psi, this investigator will halt the injection. In addition, minimum threshold current required to elicit a motor response will be recorded for conditions 3 and 4.

Procedure: Apposition of needle bevel against femoral nerve

Interventions

Indentation of femoral nerve and fascia iliaca by block needle and measurement of opening injection pressure during the controlled injection of 1 ml of dextrose (D5W) solution

Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65
  • ASA physical status I-III
  • scheduled for lower limb surgery where femoral block is part of intended analgesic plan

You may not qualify if:

  • Contraindication to femoral nerve block (e.g. infection)
  • BMI \> 35 kg/m2
  • inability to communicate postoperative symptoms
  • pre-existing neurologic deficits in the operative extremity
  • allergy to local anesthetics
  • history of opioid dependence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Luke's-Roosevelt Hospital Center

New York, New York, 10025, United States

Location

MeSH Terms

Conditions

Musculoskeletal Diseases

Study Officials

  • Malikah Latmore, MD

    Mount Sinai St. Luke's Mount Sinai Roosevelt Hospitals

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2015

First Posted

May 22, 2015

Study Start

October 1, 2014

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

April 15, 2016

Record last verified: 2015-03

Locations